Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 48 ($0.62) and last traded at GBX 49.01 ($0.63), with a volume of 10588 shares changing hands. The stock had previously closed at GBX 50.50 ($0.65).
Arecor Therapeutics Price Performance
The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The company has a 50-day moving average price of GBX 55.78 and a 200-day moving average price of GBX 67.39. The firm has a market capitalization of £18.13 million, a PE ratio of -1.70 and a beta of -0.18.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- How to Find Undervalued Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 10 Best Airline Stocks to Buy
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is Forex and How Does it Work?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
